The Belmonte lab's advanced in vivo Cas9-based epigenetic gene activation system enhances skeletal muscle mass and fiber size growth in a treated mouse (right) compared with an independent control (left). The fluorescent microscopy images show purple staining of the laminin glycoprotein in tibialis anterior muscle fibers. (Credit: Salk Institute)

Soon, we might not just be editing DNA itself, but how and when the genes it encodes are expressed. In a paper published Thursday in the journal Cell, scientists from the Salk Institute report using the gene-editing tool CRISPR in mice to alleviate symptoms of type 1 diabetes and Duchenne muscular dystrophy, without making edits to the actual genome. Instead, they used CRISPR to turn the genes on and off.

Why it matters: Genetic editing to treat disease raises questions about the ethics of permanently changing someone’s DNA. These edits are reversible. CRISPR also involves cutting both strands of DNA, which some scientists are concerned could lead to unexpected and unwanted mutations. By altering the expression of genes rather than the genetic material itself, researchers hope to avoid these potential problems and treat diseases that aren't caused by genetic mutations.

Sound smart: Epigenetics is the study of how our genes are regulated. Every cell in our body contains the same DNA, but those cells behave differently depending on which genes are turned on or off. That happens when molecules attach to them and prevent the genetic blueprint from being read. These changes are involved in a host of diseases, including some cancers, but also allow us to adjust to our environment without editing our actual genetic material. Scientists hope to harness this power to treat illnesses.

What they did: To treat type 1 diabetes, the researchers used CRISPR to convince liver cells to behave like a pancreas and produce insulin. For Duchenne muscular dystrophy, which causes muscle wasting, they turned on genes that code for follistatin, a protein that codes muscles.

Yes, but: This technique isn’t for every disease, study authors Hsin-Kai (Ken) Liao and Fumiyuki Hatanaka tell Axios. It can’t correct diseases caused by mutations, for example — something that many scientists hope CRISPR gene editing will be able to do. But it can also treat some diseases that traditional gene editing cannot.

What’s next: This study didn’t look to see if the technique was safe — just if it worked. Liao and Hatanaka say they need to make sure the body’s immune system doesn’t attack the CRISPR system being used.

Go deeper

Updated 48 mins ago - Politics & Policy

Primary races to watch in Arizona, Kansas, Michigan, Missouri, Washington

Photo: Michael B. Thomas/Getty Images

Primary elections on Tuesday in fives states see crowded fields of both Republicans and Democrats hoping to make the ballot in 2020.

What to watch: Rep. Rashida Tlaib (D-Mich.) is "fighting for her political life" in a tight primary race against Detroit City Council President Brenda Jones, who Tlaib beat by 900 votes in 2018, The New York Times writes. Senate Republicans are also watching the primary race in Kansas to see who could replace retiring Republican Sen. Pat Roberts.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 8:30 p.m. ET: 18,448,084 — Total deaths: 698,023 — Total recoveries — 11,048,174Map.
  2. U.S.: Total confirmed cases as of 8:30 p.m. ET: 4,765,170 — Total deaths: 156,668 — Total recoveries: 1,528,979 — Total tests: 57,543,852Map.
  3. States: New York City health commissioner resigns in protest of De Blasio's coronavirus response — Local governments go to war over schools.
  4. Public health: 59% of Americans support nationwide 2-week stay-at-home order in NPR poll.
  5. Politics: Trump's national security adviser returns to work after coronavirus recovery Republicans push to expand small business loan program.
  6. Sports: Indy 500 to be held without fansRafael Nadal opts out of U.S. Open.
Updated 4 hours ago - World

At least 50 killed, 3,000 injured after massive explosion rocks Beirut

Photo: Anwar Amro/AFP via Getty Images

A major explosion has slammed central Beirut, Lebanon, damaging buildings as far as several miles away and injuring scores of people.

Driving the news: Lebanon's health minister said in televised remarks that more than 50 people have been killed and over 3,000 injured. Prime Minister Hassan Diab said the explosions occurred at a warehouse that had been storing 2,750 tons of ammonium nitrate for the past six years, per NBC.